Biological immunopotentiator composition for treating cancers

A technology of biological immunity and enhancer, applied in the direction of drug combination, resistance to vector-borne diseases, medical raw materials derived from bacteria, etc., can solve problems such as unbearable for patients, high treatment costs, and difficult to promote

Inactive Publication Date: 2010-03-17
马逸冰
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] Most of the above-mentioned biological treatments that have been carried out clinically can only be carried out in hospitals with high conditions, and the treatment costs are high, which is unaffordable for ordinary patients and difficult to promote clinically.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0040] According to inactivated Salmonella typhi 500 million-15 billion, inactivated pertussis 1 billion-10 billion, diphtheria toxoid 0-2000Lf or tetanus toxoid 0-500Lf or Staphylococcus aureus enterotoxin C 0-5000ng , the ratio of polysaccharide 0-5g to prepare active ingredients, add normal saline for injection or buffer for injection, or fat emulsion for injection to prepare 100ml finished product.

Embodiment 2

[0042] According to inactivated Salmonella typhi 500 million-15 billion, inactivated pertussis 1 billion-10 billion, diphtheria toxoid 0-2000Lf or tetanus toxoid 0-500Lf or Staphylococcus aureus enterotoxin C 0-5000ng , the ratio of polysaccharide 0-5g to prepare active ingredients, add normal saline for injection or buffer for injection, or fat emulsion for injection to prepare 50ml finished product.

Embodiment 3

[0044] According to inactivated Salmonella typhi 500 million-15 billion, inactivated pertussis 1 billion-10 billion, diphtheria toxoid 0-2000Lf or tetanus toxoid 0-500Lf or Staphylococcus aureus enterotoxin C 0-5000ng , The ratio of polysaccharide 0-5g to prepare active ingredients, add normal saline for injection or buffer for injection, or fat emulsion for injection to prepare 200 ml finished product.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a biological immunopotentiator composition for treating cancers. The composition medicament for treating the cancers mainly comprises 0.5 to 15 billions of inactivated human salmonella typhi, 1 to 10 billions of inactivated bordetella pertussis, and diphtheria toxoid, tetanus toxoid or staphylococcus aureus enterotoxin C. The novel composition is helpful for activating the immune system of a tumor patient, improving the quality of life, and inhibiting tumor growth and metastasis.

Description

technical field [0001] The present invention relates to a composition for treating cancer, especially a biological immune enhancer composition for treating cancer. The composition for treating cancer mainly contains inactivated Salmonella typhi and inactivated Bacillus pertussis; and diphtheria toxoid or tetanus toxoid or Staphylococcus aureus enterotoxin C. Background technique [0002] In my country, about 2 million people suffer from cancer and 1.5 million people die of cancer every year; and it is still growing and gradually showing a younger trend. The direct economic loss caused by cancer to my country exceeds 100 billion yuan every year (from Beijing Morning News 2007 / 03 / 31). According to the report of the Ministry of Health in 2007, by 2006, the number of cancer-related deaths in my country had reached 1.8 million, which was 300,000 higher than that in 2005. The human body does not have feelings and symptoms in the early stage of tumor occurrence, so only early phy...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K35/74A61K9/107A61P35/00A61P37/04A61K31/715
CPCY02A50/30
Inventor 钟虹光吕爱平秋风卢建中李丹
Owner 马逸冰
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap